Skip to main content
ZT

Zeteo Tech

Zeteo Tech builds compact, field‑deployable biological mass spectrometers that identify airborne microbes, proteins, and lipids in near real‑time. Leveraging patent‑pending time‑of‑flight technology, their instruments provide high‑sensitivity detection of infectious diseases and bio‑threats without the need for culturing or costly reagents, enabling rapid screening for biodefense, critical infrastructure protection, and point‑of‑care diagnostics.

Sykesville, MarylandFounded 201320300+ followers
Updated 1 month ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Detecting airborne biological threats and diagnosing infectious diseases currently relies on bulky laboratory equipment, time‑consuming culturing, and expensive reagents, which limits rapid response in field or point‑of‑care settings.

Solution

Zeteo Tech offers compact, field‑deployable time‑of‑flight mass spectrometers that autonomously analyze airborne microbes, proteins, and lipids. The instruments provide near real‑time identification of bio‑threats and multiple pathogens directly from exhaled air without the need for culturing or reagent‑based assays. Their patent‑pending technology reduces size, power consumption, and cost of ownership compared with traditional MALDI systems, enabling continuous monitoring in operational environments such as critical infrastructure sites or clinical triage points. Data are processed on‑device and can be transmitted to secure networks for further analysis, supporting rapid decision‑making for biodefense and patient screening.

Target Audience

Primary customers include government and private agencies responsible for critical infrastructure protection, as well as healthcare providers and diagnostic labs seeking rapid, on‑site screening of infectious diseases.

Features

  • Miniaturized time‑of‑flight mass spectrometer optimized for aerosol sampling and high‑sensitivity detection of microbes, proteins, and lipids
  • Fully automated sample acquisition and analysis workflow with no reagent or culturing steps required
  • Near real‑time results (seconds to minutes) delivered on a handheld or portable unit
  • Low power consumption and rugged design suitable for field deployment and point‑of‑care use
  • Integrated data encryption and secure transmission for remote monitoring and reporting
  • Patent‑pending technology that lowers instrument cost and footprint relative to conventional MALDI platforms
This profile is AI-generated and may contain inaccuracies.